Study Stopped
held for blocking amendment then determined not to re-open
Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
2 other identifiers
observational
8
1 country
1
Brief Summary
This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 3, 2013
CompletedFirst Posted
Study publicly available on registry
November 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 19, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 19, 2014
CompletedSeptember 1, 2023
August 1, 2023
1.3 years
September 3, 2013
August 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patient that agree to undergo 2 biopsy's strictly for research purposes.
At 3 months
Study Arms (1)
Bone marrow aspirates and biopsy
Interventions
Eligibility Criteria
Patients who are receiving care for metastatic breast cancer at University of Michigan Rogel Cancer Center will be recruited for this study to donate samples.
You may qualify if:
- Patients with metastatic breast cancer (any site) age 21 or older
- Patients willing and able to provide informed consent \& perform study procedures
- Patients may enroll with recently (with 2 months) progressive tumor burden
- Performance status of 0,1 or 2
You may not qualify if:
- Patients unable or unwilling to provide informed consent and or perform study procedures
- Patients with active, uncontrolled coagulopathy
- Patients on treatment dose anticoagulation or an International Normalised Ratio of 2 or greater if on warfarin
- Patients who are known to be pregnant are not eligible to participate in this study during the time of the pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Biospecimen
Bone marrow, peripheral blood, tumor tissue
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Van Poznak, MD
University of Michigan Rogel Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2013
First Posted
November 4, 2013
Study Start
August 1, 2013
Primary Completion
November 19, 2014
Study Completion
November 19, 2014
Last Updated
September 1, 2023
Record last verified: 2023-08